As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

PhinC Development

5, Rue Henri Desbruères – Campus 1 – Building 8
91030 EVRY Cedex – FRANCE
Phone: +33 1 76 91 24 66

Bernard ORLANDINI: CEO, co-founder
Web Site >

#R&D Services and Products

  • Early drug development (preclinical, I and IIa phases)
  • Modeling & simulation
  • Pharmacometrics
  • Pharmacokinetics-Pharmacodynamics (PK/PD)

Field of Activity

Drug development support to biotech and small pharma companies in early phases from preclinical studies to phase IIa trials.

PhinC was founded at the Genopole biocluster in 2008 by four experienced CRO/pharmaceutical professionals with complementary competencies (pharmacology, biostatistics, pharmacokinetics, biomedical R&D).
PhinC uses an integrated and multidisciplinary approach to provide custom-tailored scientific and operational support for companies developing drug candidates. According to your needs, we can provide partial or all-inclusive services in the following fields of activity:

  • Scientific and methodological support: 

By furnishing supplementary expertise, PhinC provides support to the client’s R&D team thus allowing this latter to first conceptualize and then pilot the development of its product.
We provide pertinent counseling for fast decision making and concrete assistance for effective deployment.
Our services include the conceptualization and monitoring of preclinical and clinical trials, the development of rationale for first-in-human trials, assistance for appropriate subcontractor selection (CRO and academic) and the constitution of associated regulatory and scientific dossiers.

  • Pharmacometrics analyses: 

PhinC provides to its clients its multidisciplinary skills in pharmacokinetics (PK), pharmacodynamics (PD), PK/PD, toxicology, physiological based pharmacokinetics (PBPK), PK/QT (cardiac safety), PK population and all related statistical analyses.
Through modeling and simulation techniques, PhinC builds predictive pharmacological models allowing the optimization of drug development plans: MBDD approach (Model-Based Drug Development).

Collaborations sought

Partnership for the implementation of an integrated drug discovery platform to strengthen our drug candidate optimization activity.

  • Further Information

    16 staff members
    We offer an integrated, custom-tailored approach to optimize early-phase costs and timelines so that our clients can successfully manage their development.
    With our innovative PK/PD, biostatistics and modeling and simulation applications, we can provide support at the earliest research phases to adapt and valorize drug development.

Genopole’s Companies

#R&D Services and Products

In same field

Adlin Science - Genopole's Company

Adlin Science

ADLIN Science accompanies researchers in the management, analysis and valorization of multiomic data

Altar - entreprise génopolitaine


Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Yubsis - Genopole's company


Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations willing to improve real-time teamwork, optimize performance and accelerate innovation

Xentech - Genopole Company


XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.

Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Pymabs - Genopole's Company


R & D services in the field of transient expression of recombinant proteins in plants.

Polytheragene - Genopole's Company


Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing. Cosmetic and therapeutic molecules from plant biomass.

New England Biolabs - Genopole's Company

New England Biolabs France

New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.

LPS Biosciences - Genopole's company


LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.

Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services offers high-quality services to i) discover novel protein interactions, ii) identify the targets of drug candidates and iii) select novel, synthetic single-domain antibodies against any antigen (nanobodies).

logo abcell Bio - Genopole's Companie


Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

View all >
With the support from